Abstract
The objective of this study was to investigate the metabolic responses of normal appearing cerebellar tissue after posterior fossa tumor treatment, and to identify characteristics of the particular treatment method. Moreover, this work examined the metabolic alterations of normal appearing tissue induced by a particular tumor state including resection, stagnation, progression, and recurrence. The studied group consisted of 29 patients treated for posterior fossa tumors. All of them were irradiated with a total dose of 54 Gy at 1.8 Gy/fraction (median values). In addition, 13 underwent chemotherapy, 25 underwent total tumor resection, 18 were tumor-free in control examinations, 5 had a stable disease, and tumor progression or recurrence was observed in 2 and 4 cases, respectively. The 69 spectra, acquired using a MRI/MRS 2T system, were analyzed using Partial Least Squares Discriminant Analysis (PLS-DA) with orthogonal signal correction (OSC) spectral filtering. A significantly elevated spectral region (0.97–1.55 ppm) was observed in patients after total resection in comparison to non-operated subjects. Patients treated with chemotherapy showed an elevated band between 1.15–1.75 and 2.7–3.0 ppm and had decreases in the remaining parts of the spectra. Increases in lactate and decreases in the remaining metabolites were characteristic for the tumor progression/recurrence group. Pattern recognition methods coupled with MRS revealed significant treatment-dependent alterations in normal appearing cerebellar tissue, as well as metabolic changes induced by tumor progression/recurrence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH (2005) Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204
Chong Chong VFH, Khoo JBK, Chan LL, Rumpel H (2002) Neurological changes following radiation therapy for head and neck tumours. Eur J Radiol 44:120–129
Chu WC, Chik KW, Chan YL, Yeung DK, Roebuck DJ, Howard RG, Li CK, Metreweli C (2003) White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy. Radiology 229:659–669
Devos A, Lukas L, Suykensa JAK, Vanhamme L, Tate AR, Howe FA, Majos C, Moreno-Torres A, van der Graaf M, Arus C, van Huffel S (2004) Classification of brain tumours using short echo time 1H MR spectra. J Magn Reson 170(1):164–175
George AP, Kuehn SM, Vassilyadi M, Richards PMP, Parlow SE, Keene DL, Ventureyra ECG (2003) Cognitive sequelae in children with posterior fossa tumors. Pediatr Neurol 28:42–47
Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC (2005) Magnetic Resonance Spectroscopy. J Neuro-Ophthalmol 25:217–226
Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Changc SM, Nelson SJ (2005) Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. Am J Neuroradiol 26:760–769
Lindskog M, Spenger C, Jarvet J, Graslund A, Kogner P (2004) Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma. J Natl Cancer Inst 96:1457–1466
Lindskog M, Spenger C, Klason T, Jarvet J, Gräslund A, Johnsen JI, Ponthan F, Douglas L, Nordell B, Kogner P (2005) Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations. Cancer Lett 228:247–255
Matulewicz Ł, Sokół M, Wydmański J, Hawrylewicz L (2006) Could lipid CH2/CH3 analysis by in vivo 1H MRS help in differentiation of tumor recurrence and post-radiation effects? Folia Neuropathol 44(2):116–124
Menze BH, Lichy MP, Bachert P, Kelm BM, Schlemmer HP, Hamprecht FA (2006) Optimal classification of long echo time in vivo magnetic resonance spectra in the detection of recurrent brain tumors. NMR Biomed 19:599–609
Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65:499–508
Rutkowski T, Tarnawski R, Sokół M, Maciejewski B (2003) 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 56(5):1381–1389
Tarnawski R, Sokół M, Pieniżek P, Maciejewski B, Walecki J, Miszczyk L, Krupska T (2002) 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 52(5):1271–1276
Waldrop SM, Davis PC, Padgett CA, Shapiro MB, Morris R (1998) Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site. Am J Neuroradiol 19:963–970
Walecki J, Sokół M, Pieniżek P, Maciejewski B, Tarnawski R, Krupska T, Wydmański J, Brzeziński J, Grieb P (1999) Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients. Eur J Radiol 30:154–161
Wold S, Anttia H, Lindgrenb F, Öhman J (1998) Orthogonal signal correction of near-infrared spectra. Chemom Intell Lab Sys 44:175–185
Wold S, Sjostrom M, Eriksson L (2001) PLS-regression: a basic tool for chemometrics. Chemom Intell Lab Sys 58:109–130
Young G, Toretsky JA, Campbell AB, Eskenazi AE (2000) Recognition of common childhood malignancies. Am Fam Physician 61:2144–2154
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this paper
Cite this paper
Boguszewicz, Ł., Blamek, S., Sokół, M. (2010). Pattern Recognition Methods in 1H MRS Monitoring In Vivo of Normal Appearing Cerebellar Tissue After Treatment of Posterior Fossa Tumors. In: Czernicki, Z., Baethmann, A., Ito, U., Katayama, Y., Kuroiwa, T., Mendelow, D. (eds) Brain Edema XIV. Acta Neurochirurgica Supplementum, vol 106. Springer, Vienna. https://doi.org/10.1007/978-3-211-98811-4_31
Download citation
DOI: https://doi.org/10.1007/978-3-211-98811-4_31
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-98758-2
Online ISBN: 978-3-211-98811-4
eBook Packages: MedicineMedicine (R0)